Crossmark

Multimodal analysis disentangles the genetic and microbial associations between inflammatory bowel disease and other immune-mediated diseases across a harmonized population framework

Crossref DOI link: https://doi.org/10.1038/s41467-026-68564-4

Published Online: 2026-01-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vestergaard, Marie Vibeke https://orcid.org/0009-0006-1409-1945
Alfaro-Núñez, Alonzo https://orcid.org/0000-0002-4050-5041
Sazonovs, Aleksejs

Athanasiadis, Georgios https://orcid.org/0000-0002-2927-4035
Jess, Tine https://orcid.org/0000-0002-4391-7332
Funding

Funding for this research was provided by:

Danmarks Grundforskningsfond (DNRF148)

Danmarks Grundforskningsfond (DNRF148)

Danmarks Grundforskningsfond (DNRF148)

Novo Nordisk Fonden (NNF21OC0068631)

Novo Nordisk Fonden (NNF21OC0068631)
License Information

Text and Data Mining valid from 2026-01-21

Accepted Manuscript valid from 2026-01-21
More Information

Article History

Received: 22 May 2025

Accepted: 7 January 2026

First Online: 21 January 2026

Competing interests

: TJ reports consultancy for Ferring and Pfizer. The remaining authors have no disclosures.

Document is current

Any future updates will be listed below